Advanced search
Publication Cover
mAbs Volume 7, 2015 - Issue 6
Submit an article Journal homepage
2,096
Views
10
CrossRef citations to date
0
Altmetric
Report

Anticancer activity of TTAC-0001, a fully human anti-vascular endothelial growth factor receptor 2 (VEGFR-2/KDR) monoclonal antibody, is associated with inhibition of tumor angiogenesis

Dong Geon KimInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Samsung Medical Center; Seoul06351, Korea;Department of Health Sciences and Technology; SAIHST, Sungkyunkwan University; Seoul06351, Korea
,
Younggeon JinInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Samsung Medical Center; Seoul06351, Korea
,
Juyoun JinInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Samsung Medical Center; Seoul06351, Korea
,
Heekyoung YangInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Samsung Medical Center; Seoul06351, Korea;Department of Neurosurgery; Samsung Medical Center, Sungkyunkwan University School of Medicine; Seoul06351, Korea
,
Kyeung Min JooInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Samsung Medical Center; Seoul06351, Korea;Department of Health Sciences and Technology; SAIHST, Sungkyunkwan University; Seoul06351, Korea;Department of Anatomy and Cell Biology; Sungkyunkwan UniversitySchool of Medicine; Seoul06351, Korea
,
Weon Sup LeePharmAbcine; Inc., Daejeon Bioventure Town; Daejeon34054, Korea
,
Sang Ryeol ShimPharmAbcine; Inc., Daejeon Bioventure Town; Daejeon34054, Korea
,
Sung-Woo KimPharmAbcine; Inc., Daejeon Bioventure Town; Daejeon34054, Korea
,
Jinsang YooPharmAbcine; Inc., Daejeon Bioventure Town; Daejeon34054, Korea
,
Sang Hoon LeeBio Division, Hanwha Chemical; Seoul04541, KoreaCorrespondence[email protected] [email protected] [email protected]
,
Jin-San YooPharmAbcine; Inc., Daejeon Bioventure Town; Daejeon34054, KoreaCorrespondence[email protected] [email protected] [email protected]
&
Do-Hyun NamInstitute for Refractory Cancer Research, Research Institute for Future Medicine, Samsung Medical Center; Seoul06351, Korea;Department of Health Sciences and Technology; SAIHST, Sungkyunkwan University; Seoul06351, Korea;Department of Neurosurgery; Samsung Medical Center, Sungkyunkwan University School of Medicine; Seoul06351, KoreaCorrespondence[email protected] [email protected] [email protected]
 show all
Pages 1195-1204 | Received 16 Jan 2015, Accepted 20 Aug 2015, Published online: 18 Sep 2015

Reprints and Permissions

This is an open access article distributed under the terms of the Creative Commons CC BY license, which permits unrestricted use, distribution, reproduction in any medium, provided the original work is properly cited.

You are not required to obtain permission to reuse this article in part or whole.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.